Literature DB >> 8551445

Topical anesthesia for phacoemulsification: initial 20-case series with one month follow-up.

K D Novak1, D D Koch.   

Abstract

We report the results of our initial 20 phacoemulsification cases performed using topical anesthesia. The preferred topical regimen consisted of preservative-free 0.75% bupivacaine. Intravenous sedation was provided primarily with fentanyl and midazolam. Phacoemulsification was performed through a scleral tunnel incision, and a one-piece poly(methyl methacrylate) or three-piece silicone intraocular lens was implanted. There were no complications with the anesthetic technique. One day postoperatively, 69% of patients with a desired refractive error within 0.75 diopters of emmetropia had an uncorrected visual acuity of 20/40 or better. At one month, all patients had a best corrected acuity of 20/30 or better, and 60%, 20/20 or better. Eighteen patients reported complete intraoperative comfort, and 17 reported complete postoperative comfort. Seven of the 10 patients who had had previous peribulbar anesthesia preferred topical. All 10 "first eye" patients said they would choose topical anesthesia for future surgery. With appropriate case selection, topical anesthesia for phacoemulsification surgery can be used with excellent intraoperative and postoperative results.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8551445     DOI: 10.1016/s0886-3350(13)80564-0

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  2 in total

1.  Comparison of surgeon comfort assessment during phacoemulsification using bilateral topical anesthesia versus ipsilateral topical anesthesia: a randomized controlled study.

Authors:  Rashim Mannan; Archna Pruthi; Sumeet Khanduja
Journal:  Int Ophthalmol       Date:  2017-06-14       Impact factor: 2.031

2.  Can lubrication of the eyelid speculum reduce overall pain perception associated with cataract surgery by phacoemulsification performed under topical anesthesia?

Authors:  Rakesh K Jha; Raji Kurumkattil
Journal:  Indian J Ophthalmol       Date:  2022-05       Impact factor: 2.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.